Defunct Company
Total Trials
10
As Lead Sponsor
9
As Collaborator
1
Total Enrollment
273
NCT00265057
Study of ADH-1 Given Intravenously to Patients With Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jun 30, 2005
Completion: Jan 31, 2008
NCT00264472
A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors
Phase: Phase 1
Start: Jan 31, 2006
Completion: Not specified
NCT00390676
A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine
Start: Nov 30, 2006
Completion: Nov 30, 2009
NCT00421811
A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan
Start: Apr 30, 2007
Completion: Mar 31, 2009
NCT01231802
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
Phase: Phase 2
Start: Apr 30, 2011
Completion: Jan 31, 2013
NCT01825603
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
Role: Collaborator
Start: Apr 9, 2013
Completion: Jun 1, 2017